Uncategorized
VIDEO: New glaucoma medications target trabecular meshwork to lower IOP
NEW YORK — At OSN New York 2017, Robert J. Noecker, MD, MBA, gives an overview of the latest glaucoma therapies that work in the trabecular meshwork and are undergoing clinical trials. He said it is becoming more important to consider not only the pressure lowering of drops but also the method by which they lower IOP.